FDA is making a renewed effort to issue guidance addressing the long-languishing 510(k) third-party review program. The agency has put out a second attempt at a draft guidance to modernize and globally harmonize the program after a first-attempt draft was issued in 2013.
Enacted in the FDA Modernization Act of 1997, the third-party review program, which allows accredited organizations to conduct 510(k) reviews...





